250 related articles for article (PubMed ID: 22404155)
21. Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential.
Dungey FA; Löser DA; Chalmers AJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1188-97. PubMed ID: 18954712
[TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribose) polymerase inhibitors combined with external beam and radioimmunotherapy to treat aggressive lymphoma.
Schaefer NG; James E; Wahl RL
Nucl Med Commun; 2011 Nov; 32(11):1046-51. PubMed ID: 21956491
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016.
Russo AL; Kwon HC; Burgan WE; Carter D; Beam K; Weizheng X; Zhang J; Slusher BS; Chakravarti A; Tofilon PJ; Camphausen K
Clin Cancer Res; 2009 Jan; 15(2):607-12. PubMed ID: 19147766
[TBL] [Abstract][Full Text] [Related]
24. Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.
Nguyen D; Zajac-Kaye M; Rubinstein L; Voeller D; Tomaszewski JE; Kummar S; Chen AP; Pommier Y; Doroshow JH; Yang SX
Cell Cycle; 2011 Dec; 10(23):4074-82. PubMed ID: 22101337
[TBL] [Abstract][Full Text] [Related]
25. Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.
Zhou ZR; Zhu XD; Zhao W; Qu S; Su F; Huang ST; Ma JL; Li XY
Oncol Rep; 2013 Jun; 29(6):2498-506. PubMed ID: 23563481
[TBL] [Abstract][Full Text] [Related]
26. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
[TBL] [Abstract][Full Text] [Related]
27. Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.
Heacock ML; Stefanick DF; Horton JK; Wilson SH
DNA Repair (Amst); 2010 Aug; 9(8):929-36. PubMed ID: 20573551
[TBL] [Abstract][Full Text] [Related]
28. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose) polymerase-1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation.
Wieler S; Gagné JP; Vaziri H; Poirier GG; Benchimol S
J Biol Chem; 2003 May; 278(21):18914-21. PubMed ID: 12642583
[TBL] [Abstract][Full Text] [Related]
30. Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.
Cavallo F; Graziani G; Antinozzi C; Feldman DR; Houldsworth J; Bosl GJ; Chaganti RS; Moynahan ME; Jasin M; Barchi M
PLoS One; 2012; 7(12):e51563. PubMed ID: 23251575
[TBL] [Abstract][Full Text] [Related]
31. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Nowsheen S; Bonner JA; Yang ES
Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage.
Ding W; Liu W; Cooper KL; Qin XJ; de Souza Bergo PL; Hudson LG; Liu KJ
J Biol Chem; 2009 Mar; 284(11):6809-17. PubMed ID: 19056730
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the bromodeoxyuridine-mediated sensitization effects between low-LET and high-LET ionizing radiation on DNA double-strand breaks.
Fujii Y; Genet MD; Roybal EJ; Kubota N; Okayasu R; Miyagawa K; Fujimori A; Kato TA
Oncol Rep; 2013 Jun; 29(6):2133-9. PubMed ID: 23525528
[TBL] [Abstract][Full Text] [Related]
34. XRCC1 deficiency increased the DNA damage induced by γ-ray in HepG2 cell: Involvement of DSB repair and cell cycle arrest.
Niu Y; Zhang X; Zheng Y; Zhang R
Environ Toxicol Pharmacol; 2013 Sep; 36(2):311-319. PubMed ID: 23708312
[TBL] [Abstract][Full Text] [Related]
35. Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.
Thomas HD; Calabrese CR; Batey MA; Canan S; Hostomsky Z; Kyle S; Maegley KA; Newell DR; Skalitzky D; Wang LZ; Webber SE; Curtin NJ
Mol Cancer Ther; 2007 Mar; 6(3):945-56. PubMed ID: 17363489
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair.
King BS; Cooper KL; Liu KJ; Hudson LG
J Biol Chem; 2012 Nov; 287(47):39824-33. PubMed ID: 23038248
[TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-ribose) polymerase (PARP-1) is not involved in DNA double-strand break recovery.
Noël G; Giocanti N; Fernet M; Mégnin-Chanet F; Favaudon V
BMC Cell Biol; 2003 Jul; 4():7. PubMed ID: 12866953
[TBL] [Abstract][Full Text] [Related]
38. Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair.
Veuger SJ; Curtin NJ; Smith GC; Durkacz BW
Oncogene; 2004 Sep; 23(44):7322-9. PubMed ID: 15286704
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064.
Bowman KJ; White A; Golding BT; Griffin RJ; Curtin NJ
Br J Cancer; 1998 Nov; 78(10):1269-77. PubMed ID: 9823965
[TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets.
Chalmers AJ; Lakshman M; Chan N; Bristow RG
Semin Radiat Oncol; 2010 Oct; 20(4):274-81. PubMed ID: 20832020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
